Singapore Medical Group Limited operates in the Specialty hospitals exc. psychiatric sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Singapore Medical Group Limited with three other
health care providers in Asia:
INKON Life Technology Co Ltd
sales of 572.94 million Chinese Renmimbi [US$84.13 million]
of which 70%
was Medical services division),
Ma Kuang Healthcare Holding Limited
(1.02 billion Taiwanese Dollars [US$34.98 million]
ISEC Healthcare Ltd
(42.87 million Singapore Dollars [US$31.22 million]
of which 91%
was General Health Services).
Singapore Medical Group Limited reported sales of 94.67 million Singapore Dollars (US$68.95 million)
December of 2019.
increase of 11.3%
versus 2018, when the company's sales were 85.07 million Singapore Dollars.
Sales at Singapore Medical Group Limited have increased during each of the previous five years
(and since 2014, sales have increased a total of 257%).
Sales of Diagnostic and Aesthetics saw an increase
that was more than double the company's growth rate: sales were up
30.5% in 2019, from
24.37 million Singapore Dollars to 31.80 million Singapore Dollars.
Not all segments of Singapore Medical Group Limited experienced an increase in sales in 2019:
sales of Others fell 82.0% to 103,000.00 Singapore Dollars.
(However, this segment's sales were only a very small portion of the company's overall sales).